+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Psychedelic Neuroscience, Vol 242. Progress in Brain Research

  • ID: 4612870
  • Book
  • November 2018
  • Region: Global
  • 261 Pages
  • Elsevier Science and Technology
1 of 3

We are in the midst of what is being called the 'psychedelic renaissance' with growing interest into how psychedelics alter consciousness, brain function and brain connectivity. The acute, often profound, effects of the psychedelic experience can induce lasting improvements in mental health demonstrating that chemistry forms the basis of mystical experience, consciousness and mental wellbeing.

  • This volume is a collection of chapters by world leaders in fields of neurobiology, neuropsychiatry, psychology, ethnography and pharmacology, addressing the neurobiological mechanisms of action of various classic and atypical psychedelics, their therapeutic potential as well as the possible risks associated with their use

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 3
1. An introduction to psychedelic neuroscience Tanya Calvey and Fleur M. Howells 2. The renaissance in psychedelic research: What do preclinical models have to offer Kevin S. Murnane 3. D-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders Danilo De Gregorio, Justine P. Enns, Nicolas A. Nuñez, Luca Posa and Gabriella Gobbi 4. Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition Selen Atasoy, Jakub Vohryzek, Gustavo Deco, Robin L. Carhart-Harris and Morten L. Kringelbach 5. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder Joseph Barsuglia, Martin Polanco, Robert Palmer, Benjamin Malcolm, Benjamin Kelmendi and Tanya Calvey 6. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain Felix Müller, Matthias E. Liechti, Undine E. Lang and Stefan Borgwardt 7. Neurocognitive effects of cannabis: Lessons learned from human experimental studies Marco Colizzi and Sagnik Bhattacharyya 8. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers John Martin Corkery
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Calvey, Tanya
Dr. Tanya Calvey has a background in evolutionary neurobiology and lectures morphological anatomy in the Faculty of Health Sciences, University of the Witwatersrand. Tanya's current research is on the neuropsychopharmacology of ibogaine and substance use disorders in humans and animals. Her research team is multidisciplinary and her research is funded by the South African Medical Research Council, the South African National Research Foundation and the International Society for Neurochemistry.
Tanya is also actively involved in developing neuroscience research in Africa. She is the Secretary of the Southern African Neuroscience Society and the co-founder of the Wits Cortex Club.
Note: Product cover images may vary from those shown